Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
olomorasib (LY3537982) - Eli Lilly
Datroway (datopotamab deruxtecan-dlnk) - Daiichi Sankyo, AstraZeneca
Keytruda (pembrolizumab) - Merck (MSD)
A Study of Dato-DXd in Participants With Solid Tumors [TROPION-PanTumor04 (TP04)] (clinicaltrials.gov) - Oct 23, 2026 - P1/2 | N=268 | Recruiting | Sponsor: Daiichi Sankyo 
New P1/2 trial • Pan tumor • Genito-urinary Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Urothelial Cancer • KRAS
http://clinicaltrials.gov/ct2/show/NCT07890714
 
Oct 23, 2026
 
Prev Next